GABA (γ-aminobutyric acid) Market in India, Industry Outlook and Forecast 2024-2030

GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

This report contains market size and forecasts of GABA (γ-aminobutyric acid) in India, highlights the following information:

Sales of GABA (γ-aminobutyric acid) in India: Value 2019 VS 2023 VS 2030, ($ millions)

Sales of GABA (γ-aminobutyric acid) in India: Volume 2019 VS 2023 VS 2030, (MT)

Sales of GABA (γ-aminobutyric acid) in India: Revenue Market Share by Company, 2019-2024

Sales of GABA (γ-aminobutyric acid) in India: Volume Market Share by Company, 2019-2024

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for GABA (γ-aminobutyric acid) will continue to grow rapidly in the future.

The global GABA (γ-aminobutyric acid) market size was valued at 81 million in 2023 and is forecast to a readjusted size of US$ 124 million by 2030, with a CAGR of 6.2% during the forecast period 2024-2030.While the India GABA (γ-aminobutyric acid) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of GABA (γ-aminobutyric acid)'s global value in 2030, from % in 2023.

Our research team has surveyed the GABA (γ-aminobutyric acid) manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

India GABA (γ-aminobutyric acid) Market, By Production Process, 2019-2024, 2025-2030 ($ Millions) & (MT)

India GABA (γ-aminobutyric acid) Market Segment Percentages, By Production Process, 2023 (%)

Microbial Fermentation (Food Grade)

Microbial Fermentation (Feed Grade)

Chemical Synthesis

India GABA (γ-aminobutyric acid) Market, By Application, 2019-2024, 2025-2030 ($ Millions) & (MT)

India GABA (γ-aminobutyric acid) Market Segment Percentages, By Application, 2023 (%)

Food and Pharmaceutical

Animal Feed

Plant Growth Promoter

Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies GABA (γ-aminobutyric acid) revenues in India market, 2019-2024 (Estimated), ($ millions)

Key companies GABA (γ-aminobutyric acid) sales in India market, 2019-2024 (Estimated), (MT)

Further, the report presents profiles of competitors in the market, key players include:

Pharma Foods International

Kyowa Hakko

Sekisui Chemical

Zhejiang YiWan Biolabs

Shanghai Richen

Guangdong Luckerkong Biotech

Tianjin Shijitianlong Biotech

Ningxiang Jiayuan Biology Technology

Zhejiang Tianrui Chemical

Taizhou Xinyou Pharmaceutical & Chemical

Bloomage Freda Biopharm